chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: M
Vaccine: ANTH
Symptoms: Arthralgia, Facial palsy, Migraine
Clinical narrative: He had Bell Palsy, severe joint aches (still to date) severe migraines and we are worried about the possible birth defects in children. He was forced to take the vaccine 3 (three) times.
Age: 14.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, VARCEL
Symptoms: Convulsion, Dyskinesia, Gaze palsy, Head injury, Hyperhidrosis
Clinical narrative: 5 seconds after vaccines, patient had 30 second seizure, eyes rolled back, hit head on wall, and had upper body jerking for < 30 seconds, was then responsive, had some facial sweating.  Subsequent normal neuro exam with perrl, eomi, normal gait, and alert and oriented x 3.
Age: 14.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, VARCEL
Symptoms: Immediate post-injection reaction
Clinical narrative: 5 seconds after vaccines, patient had 30 second seizure, eyes rolled back, hit head on wall, and had upper body jerking for < 30 seconds, was then responsive, had some facial sweating.  Subsequent normal neuro exam with perrl, eomi, normal gait, and alert and oriented x 3.
Age: 1.5
Sex: F
Vaccine: HEPA
Symptoms: Blood test, Chest X-ray, Computerised tomogram, Convulsion, Crying
Clinical narrative: approximately 20hours after shot.  Awoke with 101.7 fever.  Fever rose throughout day to around 102-103.  At 7:00pm child became extremely restless and inconsolable.  Then had seizure. (Described as frontal lobe seizure by neurologist.) Became completely despondent, drooled, stared off into nothing, began breathing very rapidly, then began throat clicking, turned blue around mouth and nose, twitched/grabbed at feet when laid down.  911 was called and a wet cloth was applied. She came out of the seizure approximately 2 mins after it began.  Was transported to hospital via ambulance.  Had blood tests, chest x-ray for pnuemonia, and CT Scan.  After 11hours of waiting with no treatment was transported to another hospital for pediatric neurologist.  Was monitored/observed, had EEG done, more blood work.  All test results came back normal.  All doctors said that the shot was the cause.  Told there is 50% chance of another seizure and also same chance that she now has a seizure disorder. Released from hospital approximately 23 hours from 911 call.  9/28/07 Reviewed hospital medical records which reveal patient experienced fever, blank starring, reduced oral intake, lethargy, perioral cyanosis & seizure followed by postictal state 2 days s/p vax.  Seen at outlying ER & transferred to higher level of care.  Temp in ER was 103.  Admitted 8/30-8/31/2007 for observation.  Neuro consult done.   FINAL DX: per neuro consult seizure, atypical, associated w/fever. 9/28/07 Reviewed pcp medical records which included vax records.  VAERS database updated w/same.  Record of 8/28 reveals patient in good health on day of vax.
Age: 1.5
Sex: F
Vaccine: HEPA
Symptoms: Drooling, Electroencephalogram, Muscle twitching, Pyrexia, Respiratory rate increased
Clinical narrative: approximately 20hours after shot.  Awoke with 101.7 fever.  Fever rose throughout day to around 102-103.  At 7:00pm child became extremely restless and inconsolable.  Then had seizure. (Described as frontal lobe seizure by neurologist.) Became completely despondent, drooled, stared off into nothing, began breathing very rapidly, then began throat clicking, turned blue around mouth and nose, twitched/grabbed at feet when laid down.  911 was called and a wet cloth was applied. She came out of the seizure approximately 2 mins after it began.  Was transported to hospital via ambulance.  Had blood tests, chest x-ray for pnuemonia, and CT Scan.  After 11hours of waiting with no treatment was transported to another hospital for pediatric neurologist.  Was monitored/observed, had EEG done, more blood work.  All test results came back normal.  All doctors said that the shot was the cause.  Told there is 50% chance of another seizure and also same chance that she now has a seizure disorder. Released from hospital approximately 23 hours from 911 call.  9/28/07 Reviewed hospital medical records which reveal patient experienced fever, blank starring, reduced oral intake, lethargy, perioral cyanosis & seizure followed by postictal state 2 days s/p vax.  Seen at outlying ER & transferred to higher level of care.  Temp in ER was 103.  Admitted 8/30-8/31/2007 for observation.  Neuro consult done.   FINAL DX: per neuro consult seizure, atypical, associated w/fever. 9/28/07 Reviewed pcp medical records which included vax records.  VAERS database updated w/same.  Record of 8/28 reveals patient in good health on day of vax.
Age: 1.5
Sex: F
Vaccine: HEPA
Symptoms: Restlessness, Staring
Clinical narrative: approximately 20hours after shot.  Awoke with 101.7 fever.  Fever rose throughout day to around 102-103.  At 7:00pm child became extremely restless and inconsolable.  Then had seizure. (Described as frontal lobe seizure by neurologist.) Became completely despondent, drooled, stared off into nothing, began breathing very rapidly, then began throat clicking, turned blue around mouth and nose, twitched/grabbed at feet when laid down.  911 was called and a wet cloth was applied. She came out of the seizure approximately 2 mins after it began.  Was transported to hospital via ambulance.  Had blood tests, chest x-ray for pnuemonia, and CT Scan.  After 11hours of waiting with no treatment was transported to another hospital for pediatric neurologist.  Was monitored/observed, had EEG done, more blood work.  All test results came back normal.  All doctors said that the shot was the cause.  Told there is 50% chance of another seizure and also same chance that she now has a seizure disorder. Released from hospital approximately 23 hours from 911 call.  9/28/07 Reviewed hospital medical records which reveal patient experienced fever, blank starring, reduced oral intake, lethargy, perioral cyanosis & seizure followed by postictal state 2 days s/p vax.  Seen at outlying ER & transferred to higher level of care.  Temp in ER was 103.  Admitted 8/30-8/31/2007 for observation.  Neuro consult done.   FINAL DX: per neuro consult seizure, atypical, associated w/fever. 9/28/07 Reviewed pcp medical records which included vax records.  VAERS database updated w/same.  Record of 8/28 reveals patient in good health on day of vax.
Age: 20.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Epstein-Barr virus antibody negative, Headache, Inappropriate schedule of drug administration, Nuclear magnetic resonance imaging, Thyroid function test normal
Clinical narrative: A 20-year-old female, with no concurrent illnesses or pre-existing medical conditions, and who was taking "birth control", had received a second dose of MENACTRA, and a dose of TET TOX ADS USP on 02 August 2007. The routes and sides of administration were not reported. The patient had previously received a first dose of MENACTRA on 21 June 2007. This is not a recommended dosing schedule by the manufacturer. Two days after the second dose of MENACTRA on 02 August 2007, the patient began having severe headache located in the "frontal lobe". The headache was not relieved by MOTRIN or EXCEDRIN. The patient is able to sleep at night, and wakes without a headache but later on in the day the headache begins. She was evaluated by a physician and prescribed ZOMIG, but she did not take it as it was too expensive. An MRI was completed that was "negative", and testing for Lyme disease and thyroid function were "negative". The patient had not received any other vaccination within four weeks of the Menactra and TET TOX ADS USP on 02 August 2007. At the time of this report, the patient had not recovered. Follow-up information received on 24 September 2007 from a health care professional: the patient received first dose of MENACTRA (lot# C2770AA) on 21 July 2007. The patient received on 02 August 2007 a dose of ADACEL (Lot# U2377A) and a second dose of MENACTRA (lot# C2770AA). The patient was negative for Epstein-Barr Virus (EBV).
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Full blood count, Lymphadenopathy, Musculoskeletal stiffness, Pharyngolaryngeal pain, Pyrexia
Clinical narrative: Cluster of 2 patients (patient identification provide) developed sore throat, neck stiffness, swollen glands and fever, after receiving Menactra (lot number U1567AA), received from a health care professional in the USA on 02 May 2007. A 17 year old female patient developed throat, stiffness in the next, swollen glands and fever, 5 days after receiving Menactra (lot number U1961A, route not reported) in the left arm on 25 April 2007. She had a CDC with differential performed. At the time of the vaccination, she did not have any illness. It was reported that the recovered. Follow-up received from the health professional on 17 May 2007 stated that there was "no additional information at the time". No further information expected. The second case from same reporter is detailed in case 2007-01503.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Drug hypersensitivity, Full blood count, Lymphadenopathy, Musculoskeletal stiffness, Pharyngolaryngeal pain
Clinical narrative: Cluster of 2 patients (patient identification provided) developed sore throat, neck stiffness, swollen gland and fever, after receiving Menactra (lot number U1987AA), received from a health care professional in the USA on 02 May 2007. Case 1: A 17 year old, female patient (with an allergy to amoxicillin developed stiffness in the neck, fever, axillary swelling and pain, and sore throat, 3 days after receiving Menactra (lot number U1967AA, route not reported) in the right arm on 23 April 2007. She had a CBC with differential and PLT performed. At the time of the vaccination, she did not have any illness. It was reported that she recovered. Follow up information received on 12 July 2007 from a health care professional. The case was reviewed, and there was "no additional information." The second case from the same reporter is detailed in case 2007-01485.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Pyrexia
Clinical narrative: Cluster of 2 patients (patient identification provided) developed sore throat, neck stiffness, swollen gland and fever, after receiving Menactra (lot number U1987AA), received from a health care professional in the USA on 02 May 2007. Case 1: A 17 year old, female patient (with an allergy to amoxicillin developed stiffness in the neck, fever, axillary swelling and pain, and sore throat, 3 days after receiving Menactra (lot number U1967AA, route not reported) in the right arm on 23 April 2007. She had a CBC with differential and PLT performed. At the time of the vaccination, she did not have any illness. It was reported that she recovered. Follow up information received on 12 July 2007 from a health care professional. The case was reviewed, and there was "no additional information." The second case from the same reporter is detailed in case 2007-01485.
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Oedema peripheral
Clinical narrative: A non-serious case was received from a health professional in the United States on 15 May 2007. two female adolescent patients developed extensive limb swelling and redness at the injection site after receiving intramuscular injections of Menactra (lot numbers not reported). Patient one experienced "bright redness at the injection site and surrounding area" with "swelling of entire limb of injection site"; patient two experienced "bright redness at injection site" and "extreme swelling of upper arm where injection given". No additional information was provided, and the outcome was unknown. A corrective version was created using the receipt date 15 May 2007. This case now captures only one female adolescent patient who experienced right redness at the injection site and surrounding area" with "swelling of entire limb of injection site". An additional non-serious event of Extensive limb swelling and Injection site redness was reported by this health professional and is captured in case number 200701775.
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: An adolescent female patient experienced bright redness at injection site and "extreme" swelling of upper arm where injection was given after she had received an intramuscular injection of Menactra (lot number not provided). The outcome was unknown. A corrective version has been created using the original receipt date. The sole purpose of this version is to amend the event term from "extensive limb swelling" to "extreme swelling of upper arm". No other medically significant information has been added.
Age: 14.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Gait disturbance, Muscle tightness, Pain in extremity
Clinical narrative: A 14 year old, male patient had pain in both legs, 48 hours after he received Adacel (lot number C26C9AA) intramuscularly in the right arm and Menactra (lot number U2223AA) intramuscular in the left arm on 29 May 2007. He was seen at the physician's office with pain and tightness that persists in the right thigh. He walks with inverted "bent" knees. There were positive pulses in both legs. He was treated with Motrin and was still resolving. he did not have any illness at the time of the vaccinations. At the time of this report, he had not recovered.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Headache, Pain, Photophobia
Clinical narrative: An 18-year-old male patient had received a first dose, left deltoid, intramuscular injection of Menactra, lot number U1968AA, on 12 June 2007. The following day, the patient experienced body aches, headache, and severe light sensitivity. Concomitant medications included allergy injections. There was no illness at the time of vaccination. Relevant diagnostic testing was reported as none. At the time of this report, the patient had not recovered. The reporter in this case is the same is in case 2007-02213.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Headache, Pain, Photophobia
Clinical narrative: A 16-year-old female patient had received a first dose, left deltoid, intramuscular injection of Menactra, lot number U1968AA, on 05 June 2007. On the same day, she experienced severe body aches, headache, and light sensitivity. There was no illness on the day of vaccination. Diagnostic testing was none. The patient recovered from the event. The reporter in this case is the same as in case 2007-02212.
Age: 18.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Injection site bruising, Injection site erythema, Injection site mass, Injection site warmth
Clinical narrative: An 18-year-old female patient experienced an injection site reaction after receiving an intramuscular right deltoid injection of ADACEL (lot number C2730AA) and an intramuscular left deltoid injection of Menactra (lot number U2138AA). The patient receive both vaccinations on 14 June 2007, and the site of the ADACEL injection subsequently became black and blue, red, and warm, with a "large lump". Medical history included asthma, environmental allergies, and an amoxicillin allergy; the patient was not ill at the time of the vaccination. Concomitant medications included LEXAPRO, AVEON, and CLARITIN. The event had not yet resolved.
Age: 18.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Body temperature increased, Headache, Musculoskeletal stiffness, Nausea
Clinical narrative: A case was received from a health professional in the United States on 28 June 2007. A 17-year-old female patient with a medical history of gastric reflux, migraines, and an enlarged thyroid had received an intramuscular left deltoid injection of Menactra (lot number 02331AA) and an intramuscular right deltoid injection of Gardasil (lot number 03890) on 26 June 2007. That evening, she developed a temperature of 103 degrees Fahrenheit, nausea, headache, and stiff neck. Concomitant medications included Yasmin 28 and Nexium; the patient was not ill at the time of vaccination, and had no known allergies. Outcome was unknown.
Sex: U
Vaccine: MNQ
Symptoms: Abdominal discomfort, Asthenia, Fatigue, Headache
Clinical narrative: This case was received from a health professional in the United States on 06 July 2007. A patient experienced headaches, GI upset, fatigue, and generalized weakness after receiving an injection of Menactra (lot number not reported). No additional information was provided.
Age: 14.0
Sex: M
Vaccine: MNQ
Symptoms: Musculoskeletal stiffness, Neck pain
Clinical narrative: A 14-year-old male patient with no known history received a right deltoid intramuscular injection of Menactra (lot number U2171AA) on July 2007. On 07 July 2007 he developed left neck pain and stiffness, and treatment included Tylenol and Motrin. On 11 July 2007 he was evaluated by his physician and prescribed Motrin 600 mg and heat to the left side of the neck. Outcome was unknown.
Age: 14.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site oedema, Injection site pain, Injection site pruritus
Clinical narrative: Initial and non-serious report received from the patient's parent (a healthcare professional) on 20 August 2007. A 14-year-old female with no pre-existing medical conditions or allergies received subcutaneous injections of Menactra (lot number and site not reported) and Varicella (manufacturer, Lot number and site not reported) on 17 August 2007 and that same day she experienced pain and redness at the injection site. The following day, the injection site was very swollen (9x6 inches), indurated, edematous and itchy, with no drainage. The patient was afebrile. It was reported that the patient was to see a doctor. Recovery status had been reported as "not recovered". The patient was previously vaccinated with Gardasil (manufactured by Merck); Lot number and route/site not reported) on 18 July 2007. No additional information had been provided at the time of this report.
Age: 14.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Injection site swelling
Clinical narrative: Initial and non-serious report received from the patient's parent (a healthcare professional) on 20 August 2007. A 14-year-old female with no pre-existing medical conditions or allergies received subcutaneous injections of Menactra (lot number and site not reported) and Varicella (manufacturer, Lot number and site not reported) on 17 August 2007 and that same day she experienced pain and redness at the injection site. The following day, the injection site was very swollen (9x6 inches), indurated, edematous and itchy, with no drainage. The patient was afebrile. It was reported that the patient was to see a doctor. Recovery status had been reported as "not recovered". The patient was previously vaccinated with Gardasil (manufactured by Merck); Lot number and route/site not reported) on 18 July 2007. No additional information had been provided at the time of this report.
Age: 17.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Initial report received from a health care professional in the USA on 17 June 2007.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Dizziness, Headache, Myalgia, Pyrexia
Clinical narrative: Initial report received on 14 August 2007 from a health care professional. A 12-year-old male patient, with no illness at the time of vaccination, had received a left deltoid, intramuscular injection of MENACTRA, lot number U2286BA, on 13 August 2007. On an unspecified day in August 2007 post-immunization, the patient experienced a fever of 102.1 degrees Fahrenheit, headache, dizziness, and muscle aches. At the time of this report, the patient had not yet been evaluated by a physician and had not recovered.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Blood thyroid stimulating hormone, Fatigue, Full blood count, Hypoaesthesia, Laboratory test
Clinical narrative: An 18-year-old female patient with no relevant medical history, had received an intramuscular intramuscular left arm injection of Menactra, lot number U2393BA on 09 August 2007 and six days later complained of fatigue and numbness and tingling in her hands and feet. The patient had also received an intramuscular left deltoid injection of Gardasil (Merck), lot number 0525U on 24 July 2007. The patient had not received any concomitant medications, had no relevant medical history and had not been ill at the time of vaccination. The reporter stated that the patient had received a meningococcal immunization one year ago, however the specific vaccine was unknown at the time of the report. The reporter did not indicate any prior events had occurred. On 15 August 2007, six days after she had received the vaccine, the patient complaint of fatigue and numbness and tingling in her hands and feet. Laboratory testing had been performed 15 August 2007 which included CBC, Sed rate, BMP, TSH, and Lyme titer. All laboratory results had been pending. The reporter indicated that the patient had not yet been evaluated by their physician. No further information has been provided. At the time of the report, the patient had not recovered from the event.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Paraesthesia, Red blood cell sedimentation rate
Clinical narrative: An 18-year-old female patient with no relevant medical history, had received an intramuscular intramuscular left arm injection of Menactra, lot number U2393BA on 09 August 2007 and six days later complained of fatigue and numbness and tingling in her hands and feet. The patient had also received an intramuscular left deltoid injection of Gardasil (Merck), lot number 0525U on 24 July 2007. The patient had not received any concomitant medications, had no relevant medical history and had not been ill at the time of vaccination. The reporter stated that the patient had received a meningococcal immunization one year ago, however the specific vaccine was unknown at the time of the report. The reporter did not indicate any prior events had occurred. On 15 August 2007, six days after she had received the vaccine, the patient complaint of fatigue and numbness and tingling in her hands and feet. Laboratory testing had been performed 15 August 2007 which included CBC, Sed rate, BMP, TSH, and Lyme titer. All laboratory results had been pending. The reporter indicated that the patient had not yet been evaluated by their physician. No further information has been provided. At the time of the report, the patient had not recovered from the event.
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Hypoaesthesia
Clinical narrative: Information has been received from a nurse practitioner concerning a female who on 30-AUG-2007 was vaccinated IM in the left arm with Gardasil (lot # 658556/1060U). That same day she was also vaccinated with MENACTRA in her other (right) arm. On 31-AUG-2007 the patient woke up and her left arm and left chest wall axilla area were numb. No problems were reported at the Gardasil injection site. As of 31-AUG-2007 she had not recovered. The nurse practitioner considered the events to be "minimal" disabilities. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: DTAP, HEPA, HPV4, VARCEL
Symptoms: Abortion induced, Drug exposure during pregnancy, Inappropriate schedule of drug administration, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received from a Merck pregnancy registry for Gardasil via a nurse practitioner concerning a 17 year old female with a history of 1 pregnancy and 1 live birth with drug reactions/allergies reported as none known who on 08-MAY-2007 was vaccinated with the first dose of Gardasil (lot #656372/0243U), 0.5 ml, IM in the left deltoid. On the same day, the patient received concomitant therapy which included HAVRIX in the right deltoid, Dtap in the right arm and Varivax in the right tricep. On 21-MAY-2007, the patient came to the office since she missed her period. A urine pregnancy test was performed with results positive for pregnancy. The patient's last menstrual period (LMP) was 17-APR-2007 and expected delivery date was 22-JAN-2008. The nurse practitioner stated that the patient initially thought that she may want to obtain an abortion, but she changed her mind. This was the second pregnancy for the patient who had a 9 month old daughter. Follow-up information has been received from the nurse practitioner who reported that the patient elected to terminate the pregnancy at 12 weeks gestation. The patient's decision was not related to any medical reason. Elected to terminate the pregnancy was considered to be an other important medical event. Additional information is not expected.
Age: 23.0
Sex: F
Vaccine: MMR
Symptoms: Blood human chorionic gonadotropin positive, Drug exposure during pregnancy, Foetal disorder
Clinical narrative: Information has been received from a registered nurse concerning a 23-year-old female with no known drug allergies, who on 14-DEC-2006 was vaccinated with a subcutaneous dose of MMR II. There was no concomitant medication. A pregnancy test revealed the patient was 2 weeks pregnant (LMP= 29-NOV-2007, EDD=05-SEP-2007) at the time of vaccination. The patient sought unspecified medical attention. No other information was provided. Follow up information received indicated that there were no diagnostic tests, infections or illnesses during the pregnancy, and that no prescription drugs were taken. On 24-Aug-2007, at 39 weeks of pregnancy, a live, normal, female infant was born that weighed 8 pounds 9 ounces. There were no complications during the pregnancy, labor or delivery. However, it was also reported that the baby had unspecified congenital anomalies. The congenital anomalies were the only known complications for the infant. Additional information has been requested.
Age: 52.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Oedema peripheral, Pyrexia
Clinical narrative: Exaggerated local reaction with warmth, erythema, swelling from shoulder to elbow in arm where vaccine given (left). Also with fever up to 102.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Dizziness, Loss of consciousness
Clinical narrative: Patient given vaccine, was okay, talking and walking normal about 12 minutes after shot patient complained to mom very dizzy. Patient went unconscious. Patient was layed on floor. approx. 1 min began to rouse, legs were elevated prior to this. She was "in and out" for few minutes. Patient was given sips of coke. 40 minutes after all this, till too dizzy to stand. Sent to ER.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Dizziness, Dizziness, Dizziness postural, Immediate post-injection reaction, Loss of consciousness
Clinical narrative: Patient given vaccine, was okay, talking and walking normal about 12 minutes after shot patient complained to mom very dizzy. Patient went unconscious. Patient was layed on floor. approx. 1 min began to rouse, legs were elevated prior to this. She was "in and out" for few minutes. Patient was given sips of coke. 40 minutes after all this, till too dizzy to stand. Sent to ER.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Syncope
Clinical narrative: Patient given vaccine, was okay, talking and walking normal about 12 minutes after shot patient complained to mom very dizzy. Patient went unconscious. Patient was layed on floor. approx. 1 min began to rouse, legs were elevated prior to this. She was "in and out" for few minutes. Patient was given sips of coke. 40 minutes after all this, till too dizzy to stand. Sent to ER.
Age: 2.0
Sex: U
Vaccine: HEPA, HPV4
Symptoms: Pyrexia, Wrong drug administered
Clinical narrative: Child was administered w/wrong vax HPv at 7:00 pm 9/10/05 Right after received Hep A-Since 7:30 pm till dev. fever
Age: 0.5
Sex: F
Vaccine: DTAP, DTAPHEPBIP, HEP, IPV, RV5
Symptoms: Wrong drug administered
Clinical narrative: Gave Pediarix instead of Prevnar; no adverse reaction.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Asthenia, Blood pressure decreased, Hyperhidrosis, Pallor
Clinical narrative: Gave Menactra IM in (L) deltoid. Within 5 minutes, pt became weak, diaphoretic and pale. B/P dropped to 54/34.
Age: 13.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Computerised tomogram normal, Convulsion
Clinical narrative: Had seizure at home 9//07, went to ER head CT WNL, no fever, had episode while in ER; sent home to f/u with pediatrician 9/10/07.
Age: 40.0
Sex: M
Vaccine: ANTH, FLUX, HEP, TYP
Symptoms: Acne, Anxiety, Arthralgia, Depression, Disturbance in attention
Clinical narrative: Cramps, ache joins and muscles, anxiety, acne loss of concentration, depression, fatigue, rectal bleeding thinking abnormality, somnolence, vision blurred etc..
Age: 40.0
Sex: M
Vaccine: ANTH, FLUX, HEP, TYP
Symptoms: Fatigue, Muscle spasms, Myalgia, Rectal haemorrhage, Somnolence
Clinical narrative: Cramps, ache joins and muscles, anxiety, acne loss of concentration, depression, fatigue, rectal bleeding thinking abnormality, somnolence, vision blurred etc..
Age: 40.0
Sex: M
Vaccine: ANTH, FLUX, HEP, TYP
Symptoms: Thinking abnormal, Vision blurred
Clinical narrative: Cramps, ache joins and muscles, anxiety, acne loss of concentration, depression, fatigue, rectal bleeding thinking abnormality, somnolence, vision blurred etc..
Age: 14.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Next day and for one week thereafter, 3 weeks, red, swollen hot, hard to the touch, sore area 3 inch diameter around injection site. Benadryl PO.
Age: 7.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Next day and for 4 weeks thereafter, out arm front shoulder to elbow was red, swollen, hot to the touch, hard. Benadryl PO
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature increased, Cough, Headache, Nasopharyngitis, Vomiting
Clinical narrative: Mom moved here on 9/2/07. Mom c/o cold with cough since arrival. Her daughter moved here 9/7/07 c/o headache, vomited upon return home around 1:30PM. Temp was 100.4. Treated with Children's Tylenol, took nap. temp at 9:00pm 100.5-101.4. Treated with Motrin. School called this morning to report not feeling well.
Age: 14.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Pruritus, Urticaria
Clinical narrative: Approximately 12 hours after given IM injections in R deltoid of Menactra and Boostrix, pt. developed urticarial lesions on R upper back and RUE.  The urticaria spread to all extremities within 2 days of injections.  + itching
Age: 42.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Erythema, Oedema peripheral, Pain in extremity
Clinical narrative: Member called unit at 08:16 am with a c/o redness, soreness, and swelling in the back of his Right arm and elbow. Member did not have decending streaks, no was he febrile except for the injection site limb.  Member was assured that this is a normally expected side effect of anthrax injections.  Member was also instructed that if conditions worsen to seek immediate medical treatment and to notify the MDG of this event and to provide supporting documentation related to the treatment for this event.  A follow-up will be conducted prior to deployment.  This was number (7), a booster in the requirements for deployment.
Age: 1.02
Sex: M
Vaccine: HBHEPB, MMRV
Symptoms: Abscess, Abscess limb, Arthritis bacterial, C-reactive protein increased, Gait disturbance
Clinical narrative: On 8/9/2007, patient presented to office with fever to 102F, refusal to walk or crawl for 2 days, irritability.  He was sent to Hospital Emergency Room. He was hospitalized from 8/9-8/14, with pelvic myositis.  He was seen in office on 8/17 for follow up, not weight bearing yet but on oral clindamycin.  He was seen in office for 8/24 for follow up and still refusing to bear weight (walk).  He was sent from the office back to ER, where he was admitted again from 8/24-8/30, diagnosed with osteomyelitis of the left ileum and sacrum, with peripherally inserted central catheter placed for IV antibiotics on 8/28.  He is receiving antibiotics at home with home health care following currently.  10/05/2007 MR received for 2 hospitalizations DOS 8/09-14/2007 and 8/24-30/2007.  D/C DX for 1st admit was L pelvic myositis and fascitis.  D/C DX for 2nd admit was Osteomyelits, Pyomyositis, muscle abscess s/p drainage and septic joint s/p drainage. Initially presented to the ER with refusal to bear weight on the R leg.  Had fever night before.  PE significant for T'=101.4, minimal soft tissue swelling of the R knee. PMH: none noted.  Txd with toradol and abx and D/C 8/14/2007. Child presented again to the ER on 8/24/2007 with resusal to bear weight on the R leg.  Ortho and ID consults this admission.  Pt had an aspiration of the L SI joint and a PICC placed for IV abx. Clinical improvement shown on IV abx. Gait improved..
Age: 1.02
Sex: M
Vaccine: HBHEPB, MMRV
Symptoms: Irritability, Myositis, Nuclear magnetic resonance imaging abnormal, Osteomyelitis, Pyomyositis
Clinical narrative: On 8/9/2007, patient presented to office with fever to 102F, refusal to walk or crawl for 2 days, irritability.  He was sent to Hospital Emergency Room. He was hospitalized from 8/9-8/14, with pelvic myositis.  He was seen in office on 8/17 for follow up, not weight bearing yet but on oral clindamycin.  He was seen in office for 8/24 for follow up and still refusing to bear weight (walk).  He was sent from the office back to ER, where he was admitted again from 8/24-8/30, diagnosed with osteomyelitis of the left ileum and sacrum, with peripherally inserted central catheter placed for IV antibiotics on 8/28.  He is receiving antibiotics at home with home health care following currently.  10/05/2007 MR received for 2 hospitalizations DOS 8/09-14/2007 and 8/24-30/2007.  D/C DX for 1st admit was L pelvic myositis and fascitis.  D/C DX for 2nd admit was Osteomyelits, Pyomyositis, muscle abscess s/p drainage and septic joint s/p drainage. Initially presented to the ER with refusal to bear weight on the R leg.  Had fever night before.  PE significant for T'=101.4, minimal soft tissue swelling of the R knee. PMH: none noted.  Txd with toradol and abx and D/C 8/14/2007. Child presented again to the ER on 8/24/2007 with resusal to bear weight on the R leg.  Ortho and ID consults this admission.  Pt had an aspiration of the L SI joint and a PICC placed for IV abx. Clinical improvement shown on IV abx. Gait improved..
Age: 1.02
Sex: M
Vaccine: HBHEPB, MMRV
Symptoms: Pyrexia, Red blood cell sedimentation rate increased, Ultrasound scan abnormal, Weight bearing difficulty, White blood cell count increased
Clinical narrative: On 8/9/2007, patient presented to office with fever to 102F, refusal to walk or crawl for 2 days, irritability.  He was sent to Hospital Emergency Room. He was hospitalized from 8/9-8/14, with pelvic myositis.  He was seen in office on 8/17 for follow up, not weight bearing yet but on oral clindamycin.  He was seen in office for 8/24 for follow up and still refusing to bear weight (walk).  He was sent from the office back to ER, where he was admitted again from 8/24-8/30, diagnosed with osteomyelitis of the left ileum and sacrum, with peripherally inserted central catheter placed for IV antibiotics on 8/28.  He is receiving antibiotics at home with home health care following currently.  10/05/2007 MR received for 2 hospitalizations DOS 8/09-14/2007 and 8/24-30/2007.  D/C DX for 1st admit was L pelvic myositis and fascitis.  D/C DX for 2nd admit was Osteomyelits, Pyomyositis, muscle abscess s/p drainage and septic joint s/p drainage. Initially presented to the ER with refusal to bear weight on the R leg.  Had fever night before.  PE significant for T'=101.4, minimal soft tissue swelling of the R knee. PMH: none noted.  Txd with toradol and abx and D/C 8/14/2007. Child presented again to the ER on 8/24/2007 with resusal to bear weight on the R leg.  Ortho and ID consults this admission.  Pt had an aspiration of the L SI joint and a PICC placed for IV abx. Clinical improvement shown on IV abx. Gait improved..
Age: 1.02
Sex: M
Vaccine: HBHEPB, MMRV
Symptoms: X-ray limb abnormal, X-ray normal
Clinical narrative: On 8/9/2007, patient presented to office with fever to 102F, refusal to walk or crawl for 2 days, irritability.  He was sent to Hospital Emergency Room. He was hospitalized from 8/9-8/14, with pelvic myositis.  He was seen in office on 8/17 for follow up, not weight bearing yet but on oral clindamycin.  He was seen in office for 8/24 for follow up and still refusing to bear weight (walk).  He was sent from the office back to ER, where he was admitted again from 8/24-8/30, diagnosed with osteomyelitis of the left ileum and sacrum, with peripherally inserted central catheter placed for IV antibiotics on 8/28.  He is receiving antibiotics at home with home health care following currently.  10/05/2007 MR received for 2 hospitalizations DOS 8/09-14/2007 and 8/24-30/2007.  D/C DX for 1st admit was L pelvic myositis and fascitis.  D/C DX for 2nd admit was Osteomyelits, Pyomyositis, muscle abscess s/p drainage and septic joint s/p drainage. Initially presented to the ER with refusal to bear weight on the R leg.  Had fever night before.  PE significant for T'=101.4, minimal soft tissue swelling of the R knee. PMH: none noted.  Txd with toradol and abx and D/C 8/14/2007. Child presented again to the ER on 8/24/2007 with resusal to bear weight on the R leg.  Ortho and ID consults this admission.  Pt had an aspiration of the L SI joint and a PICC placed for IV abx. Clinical improvement shown on IV abx. Gait improved..
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC, VARCEL
Symptoms: Injection site rash, Injection site swelling, Rash generalised
Clinical narrative: lEFT THIGH AT IZ SITE SWOLLEN AND RASH DEVELOPED AT SITE. RASH THEN SPREAD THROUGHOUT BODY.
Age: 58.0
Sex: F
Vaccine: MMR
Symptoms: Rash, Rubella antibody negative
Clinical narrative: Rash over entire back
Age: 35.0
Sex: M
Vaccine: ANTH
Symptoms: Arthralgia, Local reaction, Mobility decreased, Musculoskeletal stiffness, Oedema
Clinical narrative: Large local reaction to right arm extending below the elbow. Edema, warmth to touch, joint pain to right shoulder, elbow, and wrist present. Stiffness and limited range of motion noted. Rigth axillary edema noted upon elevation of right arm for 30 minutes or more.
Age: 35.0
Sex: M
Vaccine: ANTH
Symptoms: Skin warm
Clinical narrative: Large local reaction to right arm extending below the elbow. Edema, warmth to touch, joint pain to right shoulder, elbow, and wrist present. Stiffness and limited range of motion noted. Rigth axillary edema noted upon elevation of right arm for 30 minutes or more.
Age: 1.34
Sex: M
Vaccine: HEPA, HIBV
Symptoms: Blood culture, Body temperature increased, Computerised tomogram normal, Convulsion, Laboratory test
Clinical narrative: At daycare - staff noted seizure activity and called county ambulance service. Transferred to medical center. Repeat seizure activity occurred. Transferred via ambulance to another hospital. Temperature at medical center - 101. 9/18/2007 MR received for ER visit 9/10/2007 for c/o seizure activity at daycare with additional episode in ER.  Generalized seizure in ER lasting ~5 minutes with post-icatal state after.  Eyes deviated up and to R. Temp 101'.  DX: Febrile seizure. Transfered to another facility.   MR received for o/n observation with DX:  Febrile seizure. Right Otitis Media. Pt transfered to this facility for higher level of care. Follow-up: Spiked fever of 104 first night of admission. Ear - "pink." WBC increase. Being treated with IV ROCEPHIN.
Age: 1.34
Sex: M
Vaccine: HEPA, HIBV
Symptoms: White blood cell count increased
Clinical narrative: At daycare - staff noted seizure activity and called county ambulance service. Transferred to medical center. Repeat seizure activity occurred. Transferred via ambulance to another hospital. Temperature at medical center - 101. 9/18/2007 MR received for ER visit 9/10/2007 for c/o seizure activity at daycare with additional episode in ER.  Generalized seizure in ER lasting ~5 minutes with post-icatal state after.  Eyes deviated up and to R. Temp 101'.  DX: Febrile seizure. Transfered to another facility.   MR received for o/n observation with DX:  Febrile seizure. Right Otitis Media. Pt transfered to this facility for higher level of care. Follow-up: Spiked fever of 104 first night of admission. Ear - "pink." WBC increase. Being treated with IV ROCEPHIN.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Chest pain, Dizziness, Dyspnoea, Headache, Nausea
Clinical narrative: Chest pain, shortness of breath, headache, dizziness, nausea, fever.  09/12/2007 MR received for DOS 9/6-7/2007 for admitting DX of allergic reaction MCV, dyspepsia, tachycardia.  Consult reports possible allergic reaction to meningococcal vaccine.  Diagnostic Impression:  MDD. Pt with agoraphobia.  Possible reaction to MCV.  Generalized anxiety.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Oxygen supplementation, Pyrexia
Clinical narrative: Chest pain, shortness of breath, headache, dizziness, nausea, fever.  09/12/2007 MR received for DOS 9/6-7/2007 for admitting DX of allergic reaction MCV, dyspepsia, tachycardia.  Consult reports possible allergic reaction to meningococcal vaccine.  Diagnostic Impression:  MDD. Pt with agoraphobia.  Possible reaction to MCV.  Generalized anxiety.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Urticaria
Clinical narrative: urticarial lesions on cheeks
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: pt fainted after vacc. and recovered after 5 min
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site induration, Injection site warmth
Clinical narrative: 10 cm Lge. indurated, sl. warm area to (L) deltoid
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Erythema, Skin warm
Clinical narrative: 4x6 cm pink in color - mildly warm to (R) upper arm. Benadryl and if no improvement or increased S/S to start Keflex 250/5 1/2 tsp. BID for 7 days.
Age: 0.3
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Abdominal pain, Abnormal faeces, Crying, Irritability
Clinical narrative: After 2nd Rotateq -> 6 days of intermittent fussiness with apparent abdominal pain lasting about 1 hour-6-10 x in 24 hrs-no fever-no V&D-nl BM's with foul odor-appetite normal-difficulty to console during episodes- "fine" before and after episodes
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP
Symptoms: Asthenia, Erythema, Fatigue, Headache, Hyperhidrosis
Clinical narrative: 2 hours after vaccine - headache, weakness, skin red from head to knees (appearance of sunburn). 9/7 arms and face still red c/o slight headache, tired, increased sweating. 9/8 AM red.
Age: 11.0
Sex: M
Vaccine: TDAP, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Left deltoid red, swollen, warm to touch Raniclor sample-250 mg 1 tid Atarax 10 mg/5 ml 1.5 tsp PRN every 6 hr
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site warmth, Pain
Clinical narrative: Began experienced pinkness, warmness at injection site applied cold packs 10 min next morning began experiencing pain "4" 0-> 10 scale continued cold packs
Age: 1.09
Sex: F
Vaccine: DTAP, HBHEPB, MMR, VARCEL
Symptoms: Rash
Clinical narrative: Presented to HD - while here started to develop "spots" some larger than other with the appearance of typical varicella vaccine type reaction (1) on (R) foot - (2) on leg noted. No fever. Acting normally, playing.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus
Clinical narrative: Erythema of 4-5cm, + itching, induration at site of 3 cm. No abscess.
Age: 10.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Asthma, Urticaria
Clinical narrative: Patient given Varicella vaccine 8/28/07 1 week prior patient had finished taking Prednisone for an exacerbation of asthma. Patient seen 8/30/07 - large urticarial type lesion noted left arm. 4 x 8 cm
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Culture negative, Erythema, Rash
Clinical narrative: Rash to trunk groin. Tiny vesicles surrounded by erythema. 2 weeks post Varicella injection. Culture taken. Result negative for Varicella.
Age: 40.0
Sex: M
Vaccine: ANTH, HEP, SMALL, TYP
Symptoms: Erythema, Injection site erythema, Injection site swelling, Swelling
Clinical narrative: REDNESS, SWELLING ON LEFT DELTOID WHERE SMALLPOX VACCINE WAS GIVEN.  MINOR REDNESS AND SLIGHT SWELLING RADIATING TO BENEATH THE ARM EXPERIENCED 8 DAYS POST VACCINATION. NO PAIN ASSOCIATED WITH VACCINATION.
Age: 22.0
Sex: M
Vaccine: ANTH
Symptoms: Arthralgia, Erythema, Local reaction, Mobility decreased, Oedema
Clinical narrative: Large local reaction to right arm extending below the elbow. Edema, erythema, warmth to touch, joint pain to right elbow, and limited range of motion were noted.
Age: 22.0
Sex: M
Vaccine: ANTH
Symptoms: Skin warm
Clinical narrative: Large local reaction to right arm extending below the elbow. Edema, erythema, warmth to touch, joint pain to right elbow, and limited range of motion were noted.
Age: 46.0
Sex: F
Vaccine: TD
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Swelling, redness, and pain at the site in injection.  Low grade fevers up to 101.6 F.  Treated with oral prednisone and Zyrtec.
Age: 2.0
Sex: F
Vaccine: DTAP, HBHEPB, IPV, MMRV
Symptoms: Condition aggravated, Convulsion
Clinical narrative: Child had 3 seizures on 9/8/07 after receiving shots.  Child had a history of seizure disorder.
Age: 6.0
Sex: F
Vaccine: HEP, IPV, MMR, TDAP, VARCEL
Symptoms: Anaemia, Inappropriate schedule of drug administration, Wrong drug administered
Clinical narrative: No known adverse reaction. Tdap given instead of DTaP. CDC Hot Line was called to get information about how to follow-up. Advised to file VAERS report and discount Tdap and give DTaP as soon as feasible. Dr. was notified and recommended scheduling patient for DTaP in one month.
Age: 9.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Cellulitis, Erythema, Swelling
Clinical narrative: Left deltoid red swollen on 9-10-07 pt treated for cellutlitis with Keflex 500mg
Age: 14.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Blood pressure, Hyperhidrosis, Pallor, Syncope, Syncope vasovagal
Clinical narrative: Within 5 minutes of receiving injection, patient became faint- Mom caught her and eased her to the floor.  When nurse arrived patient was responsive, but very pale and diaphoretic.  B/P 70/40.  Was transported to exam room and observed for 20 minutes.  Became fully alert and oriented, color pink and B/P 112/72 at discharge.  Dr examined her-felt that it was a vaso-vagal reaction.
Age: 1.82
Sex: M
Vaccine: DTAPHEPBIP, HIBV, MMRV
Symptoms: Erythema, Injection site erythema, Injection site swelling, Rash
Clinical narrative: About 10 minutes after giving patient an MMRV, the site was red and swelling.  About 15 minutes after MMRV given small red spots appeared on trunk. No shortness of breath or resp. distress noted.  Tylenol recommended for discomfort.  LPN
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Blood pressure, Cold sweat, Dizziness, Nausea, Pallor
Clinical narrative: Within 5 minutes of receiving injection, she became  pale, clammy and complained of dizziness and nausea.  Her B/P was 60/40.  She was transported by wheelchair to exam room and layed down with feet elevated.  Dr examined her and she was observed for 20 moinutes.  at discharge her B/P was 110/70, color pink skin warm & dry, and she was alert and oriented.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Erythema, Full blood count normal, Rash, Skin warm
Clinical narrative: On 9-7-07 pt. received DTAP (LL via IM),IPV LL via SQ),MMR(RL via SQ),and Var.(RL via SQ). Noted redness at LL on 9-7-07.  On 9-8-07 LL noted redness, warmth to touch, and rash.  Went to Hospital on 9-8-07 and ER ordered Keflex.  Rash improved on 9-9-07; however redness and warmth to touch increase. Throughout the above dates; pt's activity remained WNL.  On      9-10-07 pt. returned to our office for re-assessment; rash, redness and warmth to touch  remained to improve. PCP order Keflex 250mg for seven more days.  Pt. to f/u on 9-12-07.  DX. Immunologic Reaction vs. Cellulitis.
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Induration, Local reaction, Tenderness
Clinical narrative: Large local reaction, including 3cm area of induration with mild surrounding erythema.  Tender to palpatation.